Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3377-3384

  Magkos, Faidon ^a,b   Fabbrini, Elisa ^a,c   Mohammed, B Selma ^a   Patterson, Bruce W ^a   Klein, Samuel ^a   Mittendorfer, Bettina ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HAROKOPIO UNIVERSITY   (Greece)

^c Instituto di Ricovero e Cura a Carattere Scientifico San Raffaele   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; ESTRADIOL; FOLLITROPIN; GLUCOSE; INSULIN; PROGESTERONE; TESTOSTERONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ESTROGEN;

ABDOMINAL FAT; ADULT; ARTICLE; BODY FAT; BODY MASS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; ISOTOPE LABELING; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS OF VARIANCE; BLOOD; BODY COMPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PREMENOPAUSE;

ADULT; ANALYSIS OF VARIANCE; APOLIPOPROTEIN B-100; BODY COMPOSITION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE; SEX FACTORS; TESTOSTERONE; TRIGLYCERIDES;

EID: 77954920313     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0341     Document Type: Article

References (60)

1. National Cholesterol Education Program 2002 Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421
2. Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ 2004 Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 50:1189-1200 (Pubitemid 38824227)
3. Johnson JL, Slentz CA, Duscha BD, Samsa GP, McCartney JS, Houmard JA, Kraus WE 2004 Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 176:371-377
4. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P 1999 Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 99:1165-1172 (Pubitemid 29120088)
5. Gaspard UJ, Gottal JM, van den Brûle FA 1995 Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 21:171-178
6. Gorodeski GI 1994 Impact of the menopause on the epidemiology and risk factors of coronary artery heart disease in women. Exp Gerontol 29:357-375 (Pubitemid 24211143)
7. Milewicz A, Tworowska U, Demissie M 2001 Menopausal obesity: myth or fact? Climacteric 4:273-283
8. Weinstein I, Seltzer M, Belitsky R 1974 The interrelation of glucagon and gonadectomy upon hepatic triglyceride metabolism in rats. Biochim Biophys Acta 348:14-22
9. Elam MB, Umstot ES, Andersen RN, Solomon SS, Heimberg M 1987 Deprivation and repletion of androgen in vivo modifies triacylglycerol synthesis by rat hepatocytes. Biochim Biophys Acta 921:531-540
10. Kenagy R, Weinstein I, Heimberg M 1981 The effects of 17β-estradiol and progesterone on the metabolism of free fatty acid by perfused livers from normal female and ovariectomized rats. Endocrinology 108:1613-1621 (Pubitemid 12196260)
11. Fallat R, Glueck CJ 1974 Effects of anabolic and progestational agents upon triglycerides and triglyceride kinetics in normals and hyperlipemic patients. Lipids 9:117-120
12. Sacks FM, Walsh BW 1994 Sex hormones and lipoprotein metabolism. Curr Opin Lipidol 5:236-240
13. Mittendorfer B, Patterson BW, Klein S 2003 Effect of sex and obesity on basal VLDL-triacylglycerol kinetics. Am J Clin Nutr 77:573-579 (Pubitemid 36258564)
14. Magkos F, Patterson BW, Mohammed BS, Klein S, Mittendorfer B 2007 Women produce fewer but triglyceride-richer very low-density lipoproteins than men. J Clin Endocrinol Metab 92:1311-1318
15. Magkos F, Patterson BW, Mittendorfer B 2006 No effect of menstrual cycle phase on basal very low density lipoprotein triglyceride and apolipoprotein B-100 kinetics. Am J Physiol Endocrinol Metab 291:E1243-E1249
16. Mittendorfer B, Patterson BW, Klein S 2003 Effect of weight loss on VLDL-triglyceride and apoB-100 kinetics in women with abdominal obesity. Am J Physiol Endocrinol Metab 284:E549-E556
17. Patterson BW, Zhao G, Elias N, Hachey DL, Klein S 1999 Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J Lipid Res 40:2118-2124
18. Patterson BW, Mittendorfer B, Elias N, Satyanarayana R, Klein S 2002 Use of stable isotopically labeled tracers to measure very low density lipoprotein-triglyceride turnover. J Lipid Res 43:223-233
19. Magkos F, Patterson BW, Mittendorfer B 2007 Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res 48:1204-1211
20. Elovson J, Chatterton JE, Bell GT, Schumaker VN, Reuben MA, Puppione DL, Reeve Jr JR, Young NL 1988 Plasma very low density lipoproteins contain a single molecule of apolipoprotein B. J Lipid Res 29:1461-1473
21. Mittendorfer B, Liem O, Patterson BW, Miles JM, Klein S 2003 What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean? Diabetes 52:1641-1648
22. Levy JC, Matthews DR, Hermans MP 1998 Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21:2191-2192
23. Meier U 2006 A note on the power of Fisher's least significant difference procedure. Pharm Stat 5:253-263
24. Magkos F, Mittendorfer B 2009 Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo. Clin Lipidol 4:215-230
25. Streja D, Kallai MA, Steiner G 1977 The metabolic heterogeneity of human very low density lipoprotein triglyceride. Metabolism 26:1333-1344
26. Streja DA 1979 Triglyceride removal from very low density lipoproteins in vivo as a function of their triglyceride content. Atherosclerosis 32:57-67
27. Fisher RM, Coppack SW, Humphreys SM, Gibbons GF, Frayn KN 1995 Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase. Clin Chim Acta 236:7-17
28. Verschoor L, Chen YD, Reaven EP, Reaven GM 1985 Glucose and fructose feeding lead to alterations in structure and function of very low density lipoproteins. Horm Metab Res 17:285-288
29. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM 2002 Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 87:4166-4170
30. Mauriege P, Langin D, Montminy V, Martel C, Despres JP, Belanger A, Labrie F, Deshaies Y 2000 Effect of a long-term percutaneous adrenal steroid treatment on rat adipose tissue metabolism. Int J Obes Relat Metab Disord 24 Suppl 2:S148-S150
31. Deshaies Y, Dagnault A, Lalonde J, Richard D 1997 Interaction of corticosterone and gonadal steroids on lipid deposition in the female rat. Am J Physiol 273:E355-E362
32. Ikenoue N, Wakatsuki A, Okatani Y 1999 Small low-density lipoprotein particles in women with natural or surgically induced menopause. Obstet Gynecol 93:566-570
33. Wakatsuki A, Sagara Y 1995 Lipoprotein metabolism in postmenopausal and oophorectomized women. Obstet Gynecol 85:523-528
34. Van Beek AP, de Ruijter-Heijstek FC, Jansen H, Erkelens DW, de Bruin TW 2004 Sex steroids and plasma lipoprotein levels in healthy women: The importance of androgens in the estrogen-deficient state. Metabolism 53:187-192
35. Muscelli E, Kozàkovà M, Flyvbjerg A, Kyriakopoulou K, Astiarraga BD, Glintborg D, Konrad T, Favuzzi A, Petrie J 2009 The effect of menopause on carotid artery remodeling, insulin sensitivity, and plasma adiponectin in healthy women. Am J Hypertens 22:364-370
36. Peters HW, Westendorp IC, Hak AE, Grobbee DE, Stehouwer CD, Hofman A, Witteman JC 1999 Menopausal status and risk factors for cardiovascular disease. J Intern Med 246:521-528
37. Ozbey N, Sencer E, Molvalilar S, Orhan Y 2002 Body fat distribution and cardiovascular disease risk factors in pre- and postmenopausal obese women with similar BMI. Endocr J 49:503-509
38. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, Sutton-Tyrrell K 2009 Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 54:2366-2373
39. Glueck CJ, Fallat RW, Scheel D 1975 Effects of estrogenic compounds on triglyceride kinetics. Metabolism 24:537-545
40. Kissebah AH, Harrigan P, Wynn V 1973 Mechanism of hypertriglyceridaemia associated with contraceptive steroids. Horm Metab Res 5:184-190
41. Tikkanen MJ, Kuusi T, Nikkilä EA, Sane T 1985 Very low density lipoprotein triglyceride kinetics during hepatic lipase suppression by estrogen. Studies on the physiological role of hepatic endothelial lipase. FEBS Lett 181:160-164
42. Hazzard WR, Brunzell JD, Notter DT, Spiger MJ, Bierman EL 1973 Estrogens and triglyceride transport: increased endogenous production as the mechanism for the hypertriglyceridemia of oral contraceptive therapy. In: Scow RO, Ebling FJG, Henderson IW, eds. Endocrinology: Proceedings of the Fourth International Congress of Endocrinology (International Congress Series No. 273). Amsterdam: Excerpta Medica Foundation; 1006-1012
43. Campos H, Walsh BW, Judge H, Sacks FM 1997 Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women. J Clin Endocrinol Metab 82:3955-3963
44. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB Jr, Levy RI 1983 The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab 57:262-267
45. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM 1991 Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204
46. Godsland IF 2001 Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 75:898-915
47. Matthan NR, Jalbert SM, Lamon-Fava S, Dolnikowski GG, Welty FK, Barrett HR, Schaefer EJ, Lichtenstein AH 2005 TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status. Arterioscler Thromb Vasc Biol 25:1691-1696
48. Giannoulis MG, Jackson N, Shojaee-Moradie F, Sonksen PH, Martin FC, Umpleby AM 2006 Effects of growth hormone and/or testosterone on very low density lipoprotein apolipoprotein B100 kinetics and plasma lipids in healthy elderly men: a randomised controlled trial. Growth Horm IGF Res 16:308-317
49. Chatterjee B, Roy AK 1990 Changes in hepatic androgen sensitivity and gene expression during aging. J Steroid Biochem Mol Biol 37:437-445
50. Adiels M, Olofsson SO, Taskinen MR, Borén J 2008 Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 28:1225-1236
51. Gibbons GF, Brown AM, Wiggins D, Pease R 2002 The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly. J R Soc Med 95(Suppl 42):23-32
52. Klein S 2004 The case of visceral fat: argument for the defense. J Clin Invest 113:1530-1532
53. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD 2004 Splanchnic lipolysis in human obesity. J Clin Invest 113:1582-1588
54. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S 2009 Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
55. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S 2008 Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134:424-431
56. Völzke H, Schwarz S, Baumeister SE, Wallaschofski H, Schwahn C, Grabe HJ, Kohlmann T, John U, Dören M 2007 Menopausal status and hepatic steatosis in a general female population. Gut 56:594-595
57. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH 2004 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40:1387-1395
58. Pighon A, Barsalani R, Yasari S, Prud'homme D, Lavoie JM 19 January 2010 Does exercise training prior to ovariectomy protect against liver and adipocyte fat accumulation in rats? Climacteric 10.3109/13697130903009203
59. Paquette A, Shinoda M, Rabasa Lhoret R, Prud'homme D, Lavoie JM 2007 Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat diet. Maturitas 58:182-190
60. Jakobsen MU, Berentzen T, Sørensen TI, Overvad K 2007 Abdominal obesity and fatty liver. Epidemiol Rev 29:77-87